Pliant Therapeutics shareholders elect Coulie, Crowell, Krognes as Class III directors
PUBT · 06/11 20:52
Share
Listen to the news
- Pliant Therapeutics held its annual stockholders meeting on June 11, 2026.
- Stockholders backed the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
- A non-binding advisory resolution on executive pay received stockholder support.
- Stockholders also approved the slate of Class III director nominees for terms running to the 2029 annual meeting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pliant Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001746473-26-000092), on June 11, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved